Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$597M |
| 2 |
FRC
First Republic Bank
FRC
|
+$395M |
| 3 |
Western Midstream Partners
WES
|
+$368M |
| 4 |
Walt Disney
DIS
|
+$319M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.07B |
| 2 |
Apple
AAPL
|
+$881M |
| 3 |
Alibaba
BABA
|
+$791M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$738M |
| 5 |
Starbucks
SBUX
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.24% |
| 2 | Financials | 9.92% |
| 3 | Healthcare | 9.06% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Energy | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IEMV
2626
DELISTED
Invesco Emerging Markets Debt Value ETF
IEMV
| $7.68M | ﹤0.01% |
300,000
| – | – |
|
|
VBTX
2627
DELISTED
Veritex Holdings
VBTX
| $7.67M | ﹤0.01% |
316,830
+141,409
| +81% | +$3.58M |
|
2628
PUT
Dominion Energy
D
$60.7B
| $7.67M | ﹤0.01% |
100,000
-1,300
| -1% | -$94.9K |
|
|
CVA
2629
DELISTED
Covanta Holding Corporation
CVA
| $7.66M | ﹤0.01% |
442,737
-188,301
| -30% | -$3.08M |
|
|
GHL
2630
DELISTED
Greenhill & Co., Inc.
GHL
| $7.63M | ﹤0.01% |
354,686
+243,132
| +218% | +$6.04M |
|
2631
Scholastic
SCHL
$807M
| $7.63M | ﹤0.01% |
191,773
+30,621
| +19% | +$1.26M |
|
2632
Adeia
ADEA
$3.5B
| $7.62M | ﹤0.01% |
1,231,059
+698,174
| +131% | +$4.1M |
|
2633
iShares US Consumer Discretionary ETF
IYC
$1.21B
| $7.61M | ﹤0.01% |
149,020
-3,924
| -3% | -$193K |
|
|
MRNS
2634
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.61M | ﹤0.01% |
455,254
-36,920
| -8% | -$532K |
|
2635
Rush Enterprises Class A
RUSHA
$6.44B
| $7.61M | ﹤0.01% |
409,509
-73,471
| -15% | -$1.3M |
|
2636
Vanguard Energy ETF
VDE
$9.94B
| $7.61M | ﹤0.01% |
85,127
-5,961
| -7% | -$517K |
|
|
SLCA
2637
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.61M | ﹤0.01% |
438,198
-384,489
| -47% | -$5.51M |
|
|
HT
2638
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $7.6M | ﹤0.01% |
443,302
+178,382
| +67% | +$3.21M |
|
|
VRTU
2639
DELISTED
Virtusa Corporation
VRTU
| $7.59M | ﹤0.01% |
142,054
+26,528
| +23% | +$1.31M |
|
2640
TG Therapeutics
TGTX
$7.23B
| $7.56M | ﹤0.01% |
940,656
+178,071
| +23% | +$962K |
|
|
EXAS
2641
PUT
DELISTED
Exact Sciences
EXAS
| $7.55M | ﹤0.01% |
87,200
+70,800
| +432% | +$6.03M |
|
2642
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.42B
| $7.55M | ﹤0.01% |
+122,428
| New | +$7.44M |
|
|
BBT
2643
Beacon Financial Corp
BBT
$2.72B
| $7.55M | ﹤0.01% |
277,184
-10,752
| -4% | -$311K |
|
|
CAMP
2644
DELISTED
CalAmp Corp.
CAMP
| $7.53M | ﹤0.01% |
26,039
+959
| +4% | +$303K |
|
2645
PUT
McCormick & Company Non-Voting
MKC
$14B
| $7.53M | ﹤0.01% |
100,000
-163,400
| -62% | -$11M |
|
2646
Enpro
NPO
$7.05B
| $7.53M | ﹤0.01% |
116,868
+3,976
| +4% | +$262K |
|
2647
CALL
Sea Limited
SE
$68.5B
| $7.5M | ﹤0.01% |
+319,000
| New | +$5.59M |
|
|
MNTA
2648
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $7.47M | ﹤0.01% |
514,005
+211,588
| +70% | +$2.7M |
|
2649
CALL
Edwards Lifesciences
EW
$51.3B
| $7.46M | ﹤0.01% |
117,000
+46,500
| +66% | +$2.65M |
|
|
VIVO
2650
DELISTED
Meridian Bioscience Inc
VIVO
| $7.45M | ﹤0.01% |
423,048
+177,792
| +72% | +$2.96M |
|
Similar funds
Goldman Sachs's Q1 2019 Portfolio in Review
As of Q1 2019, Goldman Sachs held 5,713 positions worth $331B, up 5.5% from $314B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Goldman Sachs withdrew a net $23.8B in Q1 2019, closing 640 positions and reducing 2,111 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $467M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Fox Class B worth $104M.
- Goldman Sachs's largest Q1 2019 buy was Fox Class B: 2,897,722 shares worth $104M.
- Goldman Sachs added most to Pfizer in Q1 2019, an estimated $597M increase.
- Goldman Sachs's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.07B.
- Goldman Sachs fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $467M.
- Goldman Sachs's ten largest holdings make up 13% of its $331B portfolio in Q1 2019.
- Goldman Sachs opened 529 new positions and closed 640 in Q1 2019.
- Goldman Sachs's portfolio value rose 5.5% quarter-over-quarter to $331B.
Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.